We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$677M
AUM Growth
-$50M
(-6.9%)
Cap. Flow
-$67.1M
Cap. Flow
% of AUM
-9.92%
Top 10 Holdings %
Top 10 Hldgs %
11.02%
Holding
1,031
New
439
Increased
126
Reduced
146
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.2M |
| 2 |
Kimberly-Clark
KMB
|
+$8.57M |
| 3 |
SBA Communications
SBAC
|
+$7.81M |
| 4 |
PG&E
PCG
|
+$5.73M |
| 5 |
Advance Auto Parts
AAP
|
+$5.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$15.6M |
| 2 |
Pfizer
PFE
|
+$14.6M |
| 3 |
Dominion Energy
D
|
+$13.4M |
| 4 |
Johnson & Johnson
JNJ
|
+$12.9M |
| 5 |
Cadence Design Systems
CDNS
|
+$9.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.25% |
| 2 | Technology | 16.12% |
| 3 | Industrials | 11.55% |
| 4 | Financials | 11.01% |
| 5 | Healthcare | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
M/I Homes
MHO
$3.84B
| $293K | 0.04% |
3,362
-2,912
| -46% | -$206K |
|
|
HOLX
502
DELISTED
Hologic
HOLX
| $293K | 0.04% |
3,617
-14,485
| -80% | -$1.18M |
|
|
PPBI
503
DELISTED
Pacific Premier Bancorp
PPBI
| $291K | 0.04% |
+14,079
| New | +$293K |
|
504
B&G Foods
BGS
$286M
| $291K | 0.04% |
+20,905
| New | +$301K |
|
|
CHCT
505
Community Healthcare Trust
CHCT
$454M
| $290K | 0.04% |
8,794
+2,072
| +31% | +$72.1K |
|
506
ICF International
ICFI
$1.72B
| $289K | 0.04% |
+2,320
| New | +$268K |
|
|
TGI
507
DELISTED
Triumph Group
TGI
| $288K | 0.04% |
+23,269
| New | +$265K |
|
508
Unum
UNM
$14.3B
| $288K | 0.04% |
6,029
-134
| -2% | -$5.85K |
|
509
Aurinia Pharmaceuticals
AUPH
$2.11B
| $287K | 0.04% |
+29,675
| New | +$308K |
|
510
American Eagle Outfitters
AEO
$3.01B
| $286K | 0.04% |
+24,238
| New | +$302K |
|
511
RenaissanceRe
RNR
$13.4B
| $283K | 0.04% |
+1,519
| New | +$302K |
|
512
DHT Holdings
DHT
$3.02B
| $282K | 0.04% |
33,099
-27,082
| -45% | -$237K |
|
|
CPRX
513
DELISTED
Catalyst Pharmaceutical
CPRX
| $281K | 0.04% |
+20,885
| New | +$301K |
|
514
Brady Corp
BRC
$4.57B
| $279K | 0.04% |
+5,875
| New | +$295K |
|
515
Ameren
AEE
$30.1B
| $279K | 0.04% |
+3,419
| New | +$293K |
|
516
Dutch Bros
BROS
$9.26B
| $279K | 0.04% |
9,802
-25,615
| -72% | -$760K |
|
517
Vista Energy
VIST
$7.32B
| $278K | 0.04% |
+11,537
| New | +$251K |
|
518
Warrior Met Coal
HCC
$4.86B
| $277K | 0.04% |
7,121
-2,542
| -26% | -$92.1K |
|
519
Flowserve
FLS
$10.2B
| $276K | 0.04% |
+7,432
| New | +$258K |
|
|
GMS
520
DELISTED
GMS Inc
GMS
| $275K | 0.04% |
+3,974
| New | +$246K |
|
521
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $273K | 0.04% |
+4,814
| New | +$254K |
|
522
TG Therapeutics
TGTX
$7.62B
| $272K | 0.04% |
10,965
-4,772
| -30% | -$123K |
|
|
GAP
523
The Gap Inc
GAP
$7.37B
| $272K | 0.04% |
+30,447
| New | +$272K |
|
524
Leidos
LDOS
$17.3B
| $272K | 0.04% |
+3,072
| New | +$262K |
|
525
Dole
DOLE
$1.32B
| $272K | 0.04% |
+20,102
| New | +$258K |
|
Similar funds
SA
WCM
PFPGI
PG
SI
MA
TCM
HBWM
Aigen Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Aigen Investment Management held 1,031 positions worth $677M, down 6.9% from $727M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Aigen Investment Management withdrew a net $67.1M in Q2 2023, closing 320 positions and reducing 146 holdings. Its most notable exit was Pfizer, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Aigen Investment Management opened a new position in Apple worth $11.4M.
- Aigen Investment Management's largest Q2 2023 buy was Apple: 58,654 shares worth $11.4M.
- Aigen Investment Management added most to Advance Auto Parts in Q2 2023, an estimated $5.62M increase.
- Aigen Investment Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $15.6M.
- Aigen Investment Management fully exited Pfizer in Q2 2023, selling an estimated $14.6M.
- Aigen Investment Management's ten largest holdings make up 11% of its $677M portfolio in Q2 2023.
- Aigen Investment Management opened 439 new positions and closed 320 in Q2 2023.
- Aigen Investment Management's portfolio value fell 6.9% quarter-over-quarter to $677M.
Based on Aigen Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.